Hepatic gene expression in patients with obesity-related non-alcoholic steatohepatitis. - Wikidata - wikimedia - TriplyDB

Hepatic gene expression in patients with obesity-related non-alcoholic steatohepatitis.

Hepatic gene expression in patients with obesity-related non-alcoholic steatohepatitis.

http://www.wikidata.org/entity/Q46515459

about

Distinct Hepatic Macrophage Populations in Lean and Obese Mice Noninvasive biomarkers in non-alcoholic fatty liver disease: current status and a glimpse of the future.Evaluation of CXCL9 and CXCL10 as circulating biomarkers of human cardiac allograft rejection.Integrated hepatic transcriptome and proteome analysis of mice with high-fat diet-induced nonalcoholic fatty liver disease Comparative analysis of the human hepatic and adipose tissue transcriptomes during LPS-induced inflammation leads to the identification of differential biological pathways and candidate biomarkers.Identification of liver proteins altered by type 2 diabetes mellitus in obese subjects.Insulin-like growth factor binding protein-1 inhibits cancer cell invasion and is associated with poor prognosis in hepatocellular carcinoma.Gene expression profiling unravels cancer-related hepatic molecular signatures in steatohepatitis but not in steatosis Nutrigenomics of high fat diet induced obesity in mice suggests relationships between susceptibility to fatty liver disease and the proteasome.Biomarkers of NAFLD progression: a lipidomics approach to an epidemic.Analysis of global and absorption, distribution, metabolism, and elimination gene expression in the progressive stages of human nonalcoholic fatty liver disease.Weight loss amelioration of non-alcoholic steatohepatitis linked to shifts in hepatic ceramide expression and serum ceramide levels.Increased Circulating Levels of Alpha-Ketoglutarate in Morbidly Obese Women with Non-Alcoholic Fatty Liver Disease Hepatic IGFBP1 is a prosurvival factor that binds to BAK, protects the liver from apoptosis, and antagonizes the proapoptotic actions of p53 at mitochondria In silico search for modifier genes associated with pancreatic and liver disease in Cystic Fibrosis Microarray technology in the study of obesity and non-alcoholic fatty liver disease.The Ups and Downs of Insulin Resistance and Type 2 Diabetes: Lessons from Genomic Analyses in Humans The hepatic transcriptome in human liver disease Drug metabolism alterations in nonalcoholic fatty liver disease Thyroid hormone-related regulation of gene expression in human fatty liver.Characterization of hepatocellular carcinoma related genes and metabolites in human nonalcoholic fatty liver disease.TLRs, NF-κB, JNK, and Liver Regeneration.Systematic review of performance of non-invasive biomarkers in the evaluation of non-alcoholic fatty liver disease.Gene expression in human NAFLD.Non-Alcoholic Fatty Liver Disease: Current Perspectives and Future Direction in Disease pathogenesis, Treatment and Diagnosis.Identification of core gene networks and hub genes associated with progression of non-alcoholic fatty liver disease by RNA sequencing.Systematic transcriptome analysis reveals elevated expression of alcohol-metabolizing genes in NAFLD livers.An integrated view of liver injury and disease progression in nonalcoholic steatohepatitis.Functional Liver Recovery After Bariatric Surgery--a Prospective Cohort Study with the LiMAx Test.Development of gene polymorphisms in meditators of nonalcoholic fatty liver disease.Extracellular matrix and cytochrome P450 gene expression can distinguish steatohepatitis from steatosis in mice.TNFalpha-dependent hepatic steatosis and liver degeneration caused by mutation of zebrafish S-adenosylhomocysteine hydrolase.A biomarker panel for non-alcoholic steatohepatitis (NASH) and NASH-related fibrosis.Cholesterol is a significant risk factor for non-alcoholic steatohepatitis.Genome Wide Association Study Identifies the HMGCS2 Locus to be Associated With Chlorthalidone Induced Glucose Increase in Hypertensive Patients.A liver-specific long noncoding RNA with a role in cell viability is elevated in human nonalcoholic steatohepatitis.Versican: a novel modulator of hepatic fibrosis.Decreased immunoexpression of survivin could be a potential marker in human non-alcoholic fatty liver disease progression?

P2860

Q28069725-A73EF9C6-C4C1-4F99-8DB9-DEED866E1FD6 Q30432576-6B23B06D-DD44-405B-AFD5-691DD4DD0CF7 Q33247068-E941D3CD-4CE0-4ADC-A1C8-650BDBE82835 Q33543522-9CFACB62-9FBE-4CD3-AE13-924DA7C586F2 Q34042106-1663FB3F-FE51-4583-AB55-B90AFBB732C9 Q34160734-C90370C7-BB4E-48F2-A88A-F6DE53B928DF Q34371259-FD472D75-57ED-4BA0-8665-9340E4AFBD35 Q34447251-E4234AF4-0AC7-4775-A7A8-4B9B3AABB2C0 Q35064319-02EA1D8F-A202-4B09-B72B-E3E0229E2059 Q35120968-F308DE2B-CA6A-40A7-BD60-5B991545FB6B Q35264808-E35CFBC1-A004-4EE9-B53A-12769C31F4A3 Q35997786-663BDFFF-01CB-47CA-BD18-BD7FB081E0EA Q36001686-19635761-6A30-4D2F-A107-B488D33349BB Q36151062-E4D38024-4A5E-4589-8BE5-7B524FD93C1A Q36322032-DA40A954-F9B2-423C-BD98-A242C39D5CBF Q36338671-2C21895F-F9E6-4839-8484-C0D9655C2FCA Q36642598-E3451867-E35A-4FF2-9C1C-2FE78468555A Q36647336-0BEA9B9B-0B31-4563-A847-0F3F03539762 Q37120909-CF3EB71D-6271-49CD-BBF7-3FC7516A9CA4 Q37341839-7FB52A30-BB97-4A1F-8207-17E6AEB49420 Q37622144-B14A2A26-FA93-48E7-8B72-61B00E2D0CB3 Q37799257-5874A489-7A75-4799-BA05-B0E7418BB162 Q37850490-FA3CB9CB-375F-477E-A4F8-771FF2B20944 Q38292078-D462A0CE-7449-4BCD-AC39-FC30CD84BC10 Q38360416-7B9B7243-9541-4BC8-BB82-39473857F217 Q38951594-15E928E3-3FE1-4C30-858F-3D84458935F8 Q38959081-E684E207-DA06-488D-AC27-C8E456683584 Q40706260-3695D648-4BED-48FE-9E74-1F5B0F217A6E Q41078463-574EB97E-C02A-48D8-9360-A5C19E3CAC97 Q41115099-246C1EAF-7D1B-4BAB-8363-AD9632910159 Q42033362-93820907-A09E-42B3-A57D-EFF0024A0010 Q43123082-325D0C10-C918-42C3-A35A-E07C8FED6DA3 Q46177222-67D260D8-0F4D-4053-A420-A3FF8A093BA7 Q46665876-E293FD36-F2F8-43EE-BFA8-331425241A89 Q52663751-F391DBBB-4223-4F9C-8DDD-5CF1294228A7 Q52758998-2B36F6C9-435F-4FF2-83D1-8E0D09E72189 Q52889712-9A7EF548-DD78-4EE0-A875-10CCCA62C169 Q53293047-37C4DE40-0D95-4B18-B739-6100D7C1B18C

P2860

Hepatic gene expression in patients with obesity-related non-alcoholic steatohepatitis.

http://www.wikidata.org/entity/Q46515459

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh-hant

name

Hepatic gene expression in patients with obesity-related non-alcoholic steatohepatitis.

@en

Hepatic gene expression in patients with obesity-related non-alcoholic steatohepatitis.

@nl

type

label

Hepatic gene expression in patients with obesity-related non-alcoholic steatohepatitis.

@en

Hepatic gene expression in patients with obesity-related non-alcoholic steatohepatitis.

@nl

prefLabel

Hepatic gene expression in patients with obesity-related non-alcoholic steatohepatitis.

@en

Hepatic gene expression in patients with obesity-related non-alcoholic steatohepatitis.

@nl

P1433

Q46515459-5F5FFD29-3A08-44A9-828C-6604D6B32546

P1476

Q46515459-BE4C8E93-315D-429B-AAE1-184E332C42A1

P2093

Q46515459-2ABBA199-3821-464D-9652-14C10476BB29

Q46515459-467164AA-E4F3-47FF-9FD0-59BFD45C75FA

Q46515459-66F90BDD-4604-4A57-8E84-430A287E07B0

Q46515459-7AA66D87-84BF-4256-B778-7AF226F9EA05

Q46515459-81DB2176-0E69-4905-982C-B73E6C48526F

Q46515459-872F9A77-7632-402B-8DEA-01F42D95C4E2

Q46515459-CB1840C8-F448-42C1-B3B7-A5E61D00A7C9

Q46515459-CFCB0870-13E5-4752-B678-F3FF3112F64A

Q46515459-D58D3B11-CA75-4836-9A23-73FA2CB5035F

Q46515459-DDA55798-8829-4B1D-B5BE-4E27167671DA

P2860

Q46515459-1EE4F6D0-82BB-40F6-B69F-14DFACDC2B55

Q46515459-2F70F1CA-E5B4-4D9B-9EE4-E25CC9A93D92

Q46515459-2FD0328E-194E-4F8D-983D-22EF9C2D39A4

Q46515459-3349D661-5565-4C5E-BBD3-76D69360F192

Q46515459-3BA8D196-F16F-498E-876F-CF80AEDE79DF

Q46515459-3CC70DA6-00FC-432E-AE85-DB32805CA15F

Q46515459-40AE5D83-FCD1-4595-B2F6-F7F8B34BC884

Q46515459-43597378-7CDF-42FF-A9C5-E6E68002663C

Q46515459-5581769C-905A-49FB-BCB9-4A27DE55DF19

Q46515459-6D4A9CEE-8B64-4626-B439-1A3648919C0B

P304

Q46515459-7A760C05-38F5-473E-B656-68B745BD637C

P31

Q46515459-8C81F235-4115-49CC-B650-60F5BEDFDF53

P356

Q46515459-D43A0EEB-A3D4-46A3-86D7-187FA3C8598F

P433

Q46515459-CDAC916D-0421-4143-8E5F-5536B90DF713

P478

Q46515459-0F227450-A8B5-4F04-B153-02D21BA7C753

P50

Q46515459-f0c88694-481d-1d39-d045-73baff3928da

P577

Q46515459-C36E0EF0-9880-4BEE-AB91-9608AA1A4853

P698

Q46515459-191784F5-7695-4543-8181-1FD00A434963

P921

Q46515459-3BC41E0F-7136-42D8-9154-F9B985BB7434

Q46515459-83F3A959-F0EF-4EB5-B8DF-D1BE9D81D7EA

P356

J.1478-3231.2005.01117.X

P1433

Liver International

P1476

Hepatic gene expression in patients with obesity-related non-alcoholic steatohepatitis.

@en

P2093

Abraham Younoszai

http://www.w3.org/2001/XMLSchema#string

Alan Christensen

http://www.w3.org/2001/XMLSchema#string

Amy Van Meter

http://www.w3.org/2001/XMLSchema#string

Anna Baranova

http://www.w3.org/2001/XMLSchema#string

Francesco Gorreta

http://www.w3.org/2001/XMLSchema#string

Geraldine Grant

http://www.w3.org/2001/XMLSchema#string

Hazem Elariny

http://www.w3.org/2001/XMLSchema#string

Janus P Ong

http://www.w3.org/2001/XMLSchema#string

Luca Del Giacco

http://www.w3.org/2001/XMLSchema#string

Vikas Chandhoke

http://www.w3.org/2001/XMLSchema#string

P2860

Cluster analysis and display of genome-wide expression patterns

Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease.

Induction of catalase, alpha, and microsomal glutathione S-transferase in CYP2E1 overexpressing HepG2 cells and protection against short-term oxidative stress.

Prospective evaluation of unexplained chronic liver transaminase abnormalities in asymptomatic and symptomatic patients.

Cytokines in alcoholic and nonalcoholic steatohepatitis.

Clinical features and natural history of nonalcoholic steatosis syndromes.

Etiopathogenesis of nonalcoholic steatohepatitis.

Pathologic features associated with fibrosis in nonalcoholic fatty liver disease.

Chronic hepatitis C and superimposed nonalcoholic fatty liver disease.

Cryptogenic cirrhosis and posttransplantation nonalcoholic fatty liver disease.

P304

760-771

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1478-3231.2005.01117.X

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

25

http://www.w3.org/2001/XMLSchema#string

P50

P577

2005-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15998427

http://www.w3.org/2001/XMLSchema#string

P921

Steatohepatitis